HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 279, Issue 52, 54275-54282, December 24, 2004

This Article Full Text Full Text (PDF) All Versions of this Article: 279/52/54275    most recent M411482200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mahrus, S. Articles by Craik, C. S. Search for Related Content PubMed PubMed Citation Articles by Mahrus, S. Articles by Craik, C. S. Social Bookmarking                      What's this?

Granzyme M Is a Regulatory Protease That Inactivates Proteinase Inhibitor 9, an Endogenous Inhibitor of Granzyme B^*

Sami Mahrus, Walter Kisiel, and Charles S. Craik¶||

From the Chemistry and Chemical Biology Graduate Program, University of California, San Francisco, California 94143-2280, the Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico 87131-5301, and the ^¶Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94143-2280

Granzyme M is a trypsin-fold serine protease that is specifically found in the granules of natural killer cells. This enzyme has been implicated recently in the induction of target cell death by cytotoxic lymphocytes, but unlike granzymes A and B, the molecular mechanism of action of granzyme M is unknown. We have characterized the extended substrate specificity of human granzyme M by using purified recombinant enzyme, several positional scanning libraries of coumarin substrates, and a panel of individual p-nitroanilide and coumarin substrates. In contrast to previous studies conducted using thiobenzyl ester substrates (Smyth, M. J., O'Connor, M. D., Trapani, J. A., Kershaw, M. H., and Brinkworth, R. I. (1996) J. Immunol. 156, 4174–4181), a strong preference for leucine at P1 over methionine was demonstrated. The extended substrate specificity was determined to be lysine = norleucine at P4, broad at P3, proline > alanine at P2, and leucine > norleucine > methionine at P1. The enzyme activity was found to be highly dependent on the length and sequence of substrates, indicative of a regulatory function for human granzyme M. Finally, the interaction between granzyme M and the serpins ₁-antichymotrypsin, ₁ -proteinase inhibitor, and proteinase inhibitor 9 was characterized by using a candidate-based approach to identify potential endogenous inhibitors. Proteinase inhibitor 9 was effectively hydrolyzed and inactivated by human granzyme M, raising the possibility that this orphan granzyme bypasses proteinase inhibitor 9 inhibition of granzyme B.

Received for publication, October 8, 2004 , and in revised form, October 18, 2004.

^* This work was supported in part by National Institutes of Health Grant CA 72006. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

^|| To whom correspondence should be addressed. Tel.: 415-476-8146; Fax: 415-502-8298; E-mail: craik{at}cgl.ucsf.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. Bovenschen, P. J. A. de Koning, R. Quadir, R. Broekhuizen, J. M. A. Damen, C. J. Froelich, M. Slijper, and J. A. Kummer NK Cell Protease Granzyme M Targets {alpha}-Tubulin and Disorganizes the Microtubule Network J. Immunol., June 15, 2008; 180(12): 8184 - 8191. [Abstract] [Full Text] [PDF]

				G. B. Scott, J. L. Meade, and G. P. Cook Profiling killers; unravelling the pathways of human natural killer cell function Brief Funct Genomic Proteomic, January 21, 2008; (2008) elm037v1. [Abstract] [Full Text] [PDF]

				C. Bossard, K. Belhadj, F. Reyes, N. Martin-Garcia, F. Berger, J. A. Kummer, J. Briere, A.-C. Baglin, S. Cheze, J. Bosq, et al. Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials Blood, March 1, 2007; 109(5): 2183 - 2189. [Abstract] [Full Text] [PDF]

				R. Godal, U. Keilholz, L. Uharek, A. Letsch, A. M. Asemissen, A. Busse, I.-K. Na, E. Thiel, and C. Scheibenbogen Lymphomas are sensitive to perforin-dependent cytotoxic pathways despite expression of PI-9 and overexpression of bcl-2 Blood, April 15, 2006; 107(8): 3205 - 3211. [Abstract] [Full Text] [PDF]

				C. Adrain, P. J. Duriez, G. Brumatti, P. Delivani, and S. J. Martin The Cytotoxic Lymphocyte Protease, Granzyme B, Targets the Cytoskeleton and Perturbs Microtubule Polymerization Dynamics J. Biol. Chem., March 24, 2006; 281(12): 8118 - 8125. [Abstract] [Full Text] [PDF]

				B. Bade, H. E. Boettcher, J. Lohrmann, C. Hink-Schauer, K. Bratke, D. E. Jenne, J. C. Virchow Jr, and W. Luttmann Differential expression of the granzymes A, K and M and perforin in human peripheral blood lymphocytes Int. Immunol., November 1, 2005; 17(11): 1419 - 1428. [Abstract] [Full Text] [PDF]

				L. I. Pao, N. Sumaria, J. M. Kelly, S. v. Dommelen, E. Cretney, M. E. Wallace, D. A. Anthony, A. P. Uldrich, D. I. Godfrey, J. M. Papadimitriou, et al. Functional Analysis of Granzyme M and Its Role in Immunity to Infection J. Immunol., September 1, 2005; 175(5): 3235 - 3243. [Abstract] [Full Text] [PDF]